BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Žorić L, Rajović-Mrkić I, Čolak E, Mirić D, Kisić B. Optic Neuritis in a Patient with Seropositive Myelin Oligodendrocyte Glycoprotein Antibody During the Post-COVID-19 Period. Int Med Case Rep J 2021;14:349-55. [PMID: 34079389 DOI: 10.2147/IMCRJ.S315103] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Colantonio MA, Nwafor DC, Jaiswal S, Shrestha AK, Elkhooly M, Rollins S, Wen S, Sriwastava S. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis and myelitis in COVID-19: a case report and a review of the literature. Egypt J Neurol Psychiatry Neurosurg 2022;58. [DOI: 10.1186/s41983-022-00496-4] [Reference Citation Analysis]
2 Assavapongpaiboon B, Apinyawasisuk S, Jariyakosol S. Myelin oligodendrocyte glycoprotein antibody-associated optic neuritis with COVID-19 infection: A case report and literature review. American Journal of Ophthalmology Case Reports 2022;26:101491. [DOI: 10.1016/j.ajoc.2022.101491] [Reference Citation Analysis]
3 Ahmed JO, Ahmed SA, Hassan MN, Kakamad FH, Salih RQ, Abdulla BA, Rahim Fattah FH, Mohammed SH, Ali RK, Salih AM. Post COVID-19 neurological complications; a meta-analysis. Ann Med Surg (Lond) 2022;:103440. [PMID: 35261766 DOI: 10.1016/j.amsu.2022.103440] [Reference Citation Analysis]
4 Dams L, Kraemer M, Becker J. MOG-antibody-associated longitudinal extensive myelitis after ChAdOx1 nCoV-19 vaccination. Mult Scler 2021;:13524585211057512. [PMID: 34931927 DOI: 10.1177/13524585211057512] [Reference Citation Analysis]
5 Assiri SA, Althaqafi RM, Alswat K, Alghamdi A, Alomairi NE, Nemenqani DM, Ibrahim ZS, Elkady A. Post COVID-19 Vaccination-Associated Neurological Complications. NDT 2022;Volume 18:137-54. [DOI: 10.2147/ndt.s343438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
6 Aubart M, Roux CJ, Durrleman C, Gins C, Hully M, Kossorotoff M, Gitiaux C, Levy R, Moulin F, Debray A, Belhadjer Z, Georget E, Kom T, Blanc P, Wehbi S, Mazeghrane M, Tencer J, Gajdos V, Rouget S, De Pontual L, Basmaci R, Yacouben K, Angoulvant F, Leruez-Ville M, Sterlin D, Rozenberg F, Robert MP, Zhang SY, Boddaert N, Desguerre I. Neuroinflammatory Disease following Severe Acute Respiratory Syndrome Coronavirus 2 Infection in Children. J Pediatr 2022:S0022-3476(22)00426-7. [PMID: 35577119 DOI: 10.1016/j.jpeds.2022.05.018] [Reference Citation Analysis]
7 Johnsson M, Asztely F, Hejnebo S, Axelsson M, Malmeström C, Olausson T, Lycke J. SARS-COV-2 a trigger of myelin oligodendrocyte glycoprotein-associated disorder. Ann Clin Transl Neurol 2022. [PMID: 35713508 DOI: 10.1002/acn3.51609] [Reference Citation Analysis]